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HF,ZlCOBACTER pylort is the most common cause of
gastroduodenal inflammation. However, the exact
immune pathogenesis is not fully understood. To
10ok for evidence of the immunological mechan-
ism in H. pylori associated disease, we measured
cytokine interleukin-2 (IL-2) and IL-4 levels
produced by peripheral blood lymphocytes (PBL)
and gastric biopsies in 20 subjects with or without
H. pylori infection. H. pylort can stimulate IL-2
and IL-4 production from PBL in H. pylori
negative as well as H. pylort positive individuals.
The spontaneous IL-2 production by PBL and
gastric biopsies was greater (p < 0.0025, <0.001)
in H. pylori negative individuals than that in H.
pylori infected patients. Increased IL-4 levels from
PBL in H. pylori infected patients were found in
the presence of H. pylori (p < 0.0025). An
increased spontaneous production of IL-4 from
gastric biopsies was also observed in H. pylort
infected patients (p < 0.025). In conclusion, an
enhanced type 2 cytokine production was
observed in H. pylort infected patients, which may
be responsible for H. pylort chronic infection.
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Introduction
Helicobacter pylori are Gram-negative bacteria
that live in the human stomach. H. pylori infec-
tion is now recognized as one of the most
common chronic infections in man. Several lines
of evidence implicate /-/. pylori infection in gast-
roduodenal inflammation.- Colonization of the
gastric epithelium by the bacterium results in an
inflammatory reaction by both the humoral and
cellular immune responses.4 In spite of some
established observations, the exact immune
factors that contribute to pathogenetic mechan-
isms of the disease and that sustain the chronic
colonization are not fully understood.
T-helper (TH) lymphocytes may be subdivided
into TH1 and TH2 subsets based on the distinct
profiles of cytokine production. TH1 cells
produce interferon-gamma (IFN-,) and inter-
leukin-2 (IL-2) which are associated with immu-
nity or resistance to infection; whereas TH2 cells
produce IL-4, IL-5, IL-6 and IL-10 cytokines which
are associated with progression or persistence of
infection. Type 1 cytokines stimulate cellomedi-
ated immunity and type 2 cytokines stimulate
humoral immunity. Cytokines produced by one
type of TH cells can down-regulate the other
type of TH cells. Enhanced TH2 reaction, which
has an immunosuppressive role in human infec-
tion, has been found.5- To evaluate the respon-
sive conditions of TH1 and TH2 cells in subjects
with H. pylori infection, we measured IL-2 pro-
duced by TH1 cells and IL-4 produced by TH2
cells in supernatants from peripheral blood lym-
phocytes (PBL) and gastric biopsies in these
subjects.
Subjects and Methods
Subjects: Twenty subjects with dyspepsia attend-
ing for upper gastrointestinal endoscopy were
studied. None of the subjects had recently
received non-steroidal anti-inflammatory drugs,
bismuth compounds or antibiotics. Patients with
evidence of malignant disease or immunosup-
pression were excluded. A rapid urease test
(CLO-test, Delta West Ltd, Australia) and a histo-
logical examination by using a Giemsa stain were
applied for evaluating the status of H. pylori
infection. Subjects were designated as H. pylori
positive on the basis of CLO testing or histologi-
cal examination by Giemsa stain. Of 20 subjects,
ten (seven men and three women; mean age 44.6
years, range 20-70) had H. pylori infection,
including six with duodenal ulcer and four with
gastritis alone. Ten (six men and four women;
mean age 46.8 years, range 22-67) were H.
pylori negative subjects with normal results of
gastrointestinal endoscopy and histology.
(C) 1995 Rapid Science Publishers Mediators of Inflammation Vol 4 1995 289
X G. Fanetal.
H. pylori: H. pylori preparation was made by
sonicating a mixture of H. pylori bacterial cul-
tures obtained from six patients (four with duo-
denal ulcer and two with gastritis alone) on ice
using 6 x 15 s, 100 watt pulses, with 30 s cooling
intervals, followed by irradiation at 4000 rads to
sterilize the preparation. It was then washed with
phosphate buffered saline (PBS) and stored at
_20C.3,9
PBL: PBL were isolated by Ficoll-Hypaque
density-gradient centrifugation, washed and sus-
pended in RPMI 1640 medium containing 100 U/
ml penicillin, 100 gg/ml streptomycin, 20mM L-
glutamine and 10% fetal calf serum. The number
and viability of the isolated PBL were determined
using acridine orange/ethidium bromide (EB/
AO). PBL (2 x 105/well) were seeded into each
well of the 96-well plates. Duplicate cultures were
incubated with H. pylori (final concentration
30 l.tg/ml), phytohaemagglutinin (PHA, 10 gtg/ml
as positive control) or the medium alone,
respectively, at 37C in 5% CO2. After 72h
culture, supernatants were collected and stored
at -70C until cytokine assay.
Gastric biopsies: Multiple biopsy specimens were
obtained during upper gastrointestinal endo-
scopy from adjacent sites of the gastric antrum
for H. pylori histological examination, CLO-test
and incubation. Biopsies for incubation were
immediately washed twice with the medium and
then cultured in I ml of culture medium at 37C
in 5% CO2. Following a 24h incubation, super-
natants were collected by centrifugation and
10stored at -70 C until cytokine assay.
Measurements of IL-2 and IL-4: IL-2 and IL-4
were measured by EIA Kits (Advanced Magnetics
Inc., Cambridge, MA, USA). Assays were per-
formed in duplicate according to the manufac-
turer’s instructions.
Table 1. IL-2 levels in supernatants from lymphocytes (pg/ml)
IL-2
Spontaneous PHA H. pylori
H. pylori
negative subjects
Median 19.80*
Range 11.96-25.52
No. 10
H. pylori
positive subjects
Median 14.38
Range 10.12-21.18
No. 10
102.9 30.38
58.32-155.3 20.75-47.24
10 10
104.7 30.66
50.68-162.4 18.95-45.25
10 10
*p < 0.0025 vs. H. pylori positive subjects.
PHA or H. pylori stimulation in both of the two
groups (Table 1).
There was decreased IL-2 production in super-
natants from cultured gastric biopsies in patients
with H. pylori infection when compared with
subjects without (Table 2).
IL-4 levels.. In the absence of PHA or /-/. pylori,
no significant difference was found for IL-4 levels
in supernatants from cultured PBL between H.
pylori negative and positive subjects. Stimulation
Table 2. IL-2 and IL-4 production in supernatants from cultured
gastric biopsies (pg/g wet wt)
IL-2 IL-4
(n= 10) (n= 10)
H. pylori
negative subjects
Median
Range
H. pylori
positive subjects
Median
Range
635.1" 47.91"*
359.1-1368 16.24-67.28
337.3 67.57
141.8-576.8 28.28-101.3
*p < 0.0025 or **p < 0.025 vs. H. pylori positive subjects, respectively.
Statistics: Data were expressed as medians and
ranges. Statistical analysis was carded out using
Mann-Whitney U-test.
Results
IL-2 levels: H. pylori negative subjects had a sig-
nificantl higher IL-2 level in supernatants from
resting PBL compared with those having H.
pylori infection. However, there was no sig-
nifican difference between these two groups in
IL-2 levels of supernatants from PBL, which were
stimulated with PHA or H. pylori although an
increase in IL-2 production was found following
Table 3. IL-4 level in supernatants from lymphocytes (pg/ml)
IL-4
Spontaneous PHA H. pylori
H. pylori
negative subjects
Median 10.87
Range 5.92-15.24
No. 10
H. pylori
positive subjects
Median 11.86
Range 6.48-17.48
No. 10
44.0 21.71
19.92-60.65 18.81-38.40
10 10
43.36 30.23
23.30-64.90 23.77-42.18
10 10
*p < 0.0025 vs. H. pylori positive subjects.
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IL-2 and IL-4 in H. pylori infection
with /-L. pylori resulted in higher production of explanation why H. pylori infection is a chronic
It-4 from PBL in H. lylori infected patients than condition, possibly lasting for decades, if not for
that in/-L, pylori negative individuals. Although an life.
increase in IL-4 production was observed in It has been demonstrated previously that H.
supernatants from PHA activated PBL in all sub- pylori can activate PBL to release inflammatory
jects, IL-4 production was not significantly differ- cytokines.16’17 Also, a higher gastric cytokine con-
ent between the two groups (Table 3). centration is present in /-L. pylori positive
A significantly higher level of IL-4 in super- patients.18 In the present data, although PHA can
natants from cultured gastric biopsies was stimulate cytokine production from PBL, no sig-
observed in H. pylori infected patients compared nificant difference was found between H. pylori
to H. pylori negative subjects (Table 2). positive and negative groups in IL-4 production,
suggesting this may be a specific response to H.
pylori for H. pylori infected hosts. It has been
Discussion known that IL-4 can inhibit the synthesis of IFN-T
(type 1 cytokine).9’2 Suppressed proliferative
Understanding host responses to infection responses of peripheral blood and gastric lym-
requires knowledge of the regulatory mechan- phocytes and decreased production of IFNq,
isms that affect the outcome of infection by the from PBL and gastric lamina propria lymphocytes
pathogen. The majority of individuals exposed have also been demonstrated in patients with H.
develop a powerful cellular immune response to pylori colonization,6’2’22 implying that specific
the pathogen, which results in elimination of the T-cell responses are down-regulated by type 2
infection. Some individuals are unable to mount cytokines, and enhanced IL-4 profile is respon-
a sufficient immune response so that the infec- sible for decreased production of IFN-T in H.
tion proceeds unabated. A few studies have pylori infection. Further experimental observa-
reported that IL-4 has negative immunoregulatory tions will be required to investigate whether the
function in some infectious diseases, such as balance between TH1 and TH2 responses would
acquired immunodeficiency syndrome, leprosy be restored by use of recombinant type 1 cyto-
and tuberculosis.5’’12 Enhanced TH2 reaction kines and anti-type 2 cytokine antibodies, or fol-
and down-regulation of the cellular immune lowing eradication of H. pylori in the infected
responses have been proposed in H. pylori patients.
infected patients.’1 The study showed that More fundamentally, treatment of H. Iylori is
increased IL-4 and decreased IL-2 production was difficult because H. pylori’s habitat below the
observed in PBL as well as in gastric biopsies layer of gastric mucus hinders the necessary
from H. pylori infected patients, providing access of antimicrobials. Also, bacterial resistance
experimental evidence that enhanced TH2 reac- to antimicrobials is the main problem with
tion is present in H. pylori infected patients and current treatment regimes.2 Thus, antibacterial
may play an important role in the immune treatment and effective immune responses will
pathogenesis of H. pylori infection, both be of importance in the eradication of H.
Microbial and host factors that affect the clear- pylori. We might be able to induce proper
ance of H. pylori from gastric tissue have not immune responses in H. pylori positive hosts
been fully identified. Despite the fact that hosts and ultimately eradicate the bacterium. We might
with H. pylori infection may have immune or use some agents to reduce the overproduction of
inflammatory responses to H. l/lori, the disease type 2 cytokines or to favour the secretion of
12still persists.’ A TH1 to TH2 reaction shift may type 1 cytokines. The administration of recombi-
be one of several important factors in this situa- nant type 1 cytokines could be beneficial to H.
tion. Although the majority of people colonized pylori infected hosts. Anti-type 2 cytokine anti-
with H. pylori elicit strong, specific circulating bodies or type 2 cytokine receptor antagonists
and gastric mucosal antibody responses, the could be used to restore the balance between
humoral response seems ineffective at eradicating TH1 and TH2 responses in such patients and
14 15 TH1H. pylori. Suppressed and enhanced thus eliminate the organism.
TH2 responses in H. pylori infection may imply
that the human host attempts to down-regulate
the inflammatory responses and reduce the tissue References
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